307 Results

People

  1. Old
    Old
  2. Ritter
    Ritter
  3. Allison
    Allison
  4. Rudensky
    Rudensky
  5. Gnjatic
    Gnjatic
  6. Wolchok
    Wolchok
  7. Jungbluth
    Jungbluth
  8. O'Reilly
    O'Reilly
  9. Pamer
    Pamer
  10. Yuan
    Yuan

Groups

  1. GSK Faculty (144)
  2. Department of Medicine (131)
  3. Sloan Kettering Institute Faculty (108)
  4. Sloan Kettering Institute Postdocs (90)
  5. Immunology Program Faculty (76)
  6. Hematologic Malignancies, Division of (67)
  7. Center for Hematologic Malignancies (64)
  8. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (60)
  9. Solid Tumor Oncology Division (58)
  10. Center for Molecular Imaging and Biotechnology (49)
  1. "cd4+ t lymphocyte"
Formats
  1. Journal Article (288)
  2. Review (10)
  3. Editorial (5)
  4. Research Letter (2)
  5. Conference Paper (1)
  6. Guidelines (1)
Groups
  1. GSK Faculty (144)
  2. Department of Medicine (131)
  3. Sloan Kettering Institute Faculty (108)
  4. Sloan Kettering Institute Postdocs (90)
  5. Immunology Program Faculty (76)
  6. Hematologic Malignancies, Division of (67)

More Groups

People
  1. Lloyd Old (31)
  2. Jedd Wolchok (26)
  3. Gerd Ritter (23)
  4. Alexander Rudensky (21)
  5. James Allison (21)
  6. Sacha Gnjatic (19)

More People

Years
  1. 2025 (12)
  2. 2024 (28)
  3. 2023 (12)
  4. 2022 (13)
  5. 2021 (10)
  6. 2020 (11)

More Years

Publications
  1. Blood (22)
  2. Journal of Immunology (21)
  3. Clinical Cancer Research (15)
  4. Journal of Experimental Medicine (13)
  5. Nature (11)
  6. PLoS ONE (11)

More Publications

Publishers
  1. Nature Publishing Group (40)
  2. American Society of Hematology (30)
  3. American Association for Cancer Research (27)
  4. Elsevier Inc. (22)
  5. The American Association of Immunologists, Inc (21)
  6. Cell Press (18)

More Publishers

Results (307)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The dynamic immune behavior of primary and metastatic ovarian carcinoma
    Journal Article

    Stur, E.; Peng, F.; Teng, P. N.; Bayraktar, E.; Hu, M.; Corvigno, S.; Brown, D. J.; Lee, S.; Moore, K. N.; Bateman, N. W.; more...
    npj Precision Oncology (2025)

    Fulltext@MSK | Save
  • IL-2Rα is dispensable for murine B cell development and humoral response
    Journal Article

    Chowdhury, P.; Belcheva, K. T.; Smolkin, R. M.; Cols, M.; Fontenot, J. D.; Yewdell, W. T.; Chaudhuri, J.
    Journal of Immunology (2025)

    Fulltext@MSK | Save
  • The influence of the germline HSD3B1 adrenal-permissive allele (c.1100 C) on the somatic alteration landscape, the transcriptome, and immune cell infiltration in prostate cancer
    Journal Article

    Kellen, S.; Makovec, A.; Miller, C. D.; Nazari, S. S.; Elliott, A.; Deacon, A.; John, E.; Vobugari, N.; Agarwal, N.; McKay, R. R.; more...
    Cancers (2025)

    Fulltext@MSK | Save
  • Bodyweight and absolute lymphocyte count-based dosing of rabbit anti-thymocyte globulin results in early CD4+ immune reconstitution in patients with inborn errors of metabolism undergoing umbilical cord blood transplantation
    Journal Article

    Drozdov, D.; Kandil, J.; Long, S. E.; Demorest, C. V.; Cao, Q.; Lund, T. C.; Gupta, A. O.; Boelens, J. J.; Orchard, P. J.
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  • Phase 1 clinical trial of B-cell maturation antigen (BCMA) NEX-T® chimeric antigen receptor (CAR) T cell therapy CC-98633/BMS-986354 in participants with triple-class exposed multiple myeloma
    Journal Article

    Ravi, G.; Richard, S.; Kumar, S.; Atrash, S.; Liedtke, M.; Kaur, G.; Derman, B.; Bergsagel, P. L.; Mailankody, S.; McCarthy, P.; more...
    Leukemia (2025)

    Fulltext@MSK | Save
  • The response to anti–PD-1 and anti–LAG-3 checkpoint blockade is associated with regulatory T cell reprogramming
    Journal Article

    Rolig, A. S.; Peng, X.; Sturgill, E. R.; Holay, N.; Kasiewicz, M.; Mick, C.; McGee, G. H.; Miller, W.; Koguchi, Y.; Kaufmann, J.; more...
    Science Translational Medicine (2025)

    Fulltext@MSK | Save
  • Germline prediction of immune checkpoint inhibitor discontinuation for immune-related adverse events
    Journal Article

    Middha, P.; Thummalapalli, R.; Quandt, Z.; Balaratnam, K.; Cardenas, E.; Falcon, C. J.; Princess Margaret Lung Group; Gubens, M. A.; Huntsman, S.; Khan, K.; more...
    Journal for ImmunoTherapy of Cancer (2025)

    Fulltext@MSK | Save
  • Targeting HLA-E-overexpressing cancers with a NKG2A/C switch receptor
    Journal Article

    Sætersmoen, M.; Kotchetkov, I. S.; Torralba-Raga, L.; Mansilla-Soto, J.; Sohlberg, E.; Krokeide, S. Z.; Hammer, Q.; Sadelain, M.; Malmberg, K. J.
    Med (2025)

    Fulltext@MSK | Save
  • Biological correlates associated with high-risk breast cancer patients identified using a computational method
    Journal Article

    Oh, J. H.; Pareja, F.; Elkin, R.; Xu, K.; Norton, L.; Deasy, J. O.
    npj Breast Cancer (2025)

    Fulltext@MSK | Save
  • CD4+ T-cell lymphoma harboring a chimeric antigen receptor integration in TP53
    Journal Article

    Perica, K.; Jain, N.; Scordo, M.; Patel, R.; Eren, O. C.; Patel, U.; Gundem, G.; Domenico, D.; Mitra, S.; Socci, N. D.; more...
    New England Journal of Medicine (2025)

    Fulltext@MSK | Save